New-Onset Diabetes after Transplant (NODAT)

The estimated rates at 12 months posttransplant are 20–50% for kidney transplants, 9–21% for liver transplants, and approximately 20% for lung transplants. NODAT is associated with increased risks of graft rejection, infection, cardiovascular disease, and death. Besides the traditional risk factors for type 2 diabetes (age, family history, obesity, and ethnicity), exposure to immunosuppressive agents often precedes the occurrence of NODAT.

Below are some articles related to NODAT :

http://jcem.endojournals.org/content/96/11/3289.full

http://jasn.asnjournals.org/content/17/12_suppl_3/S291.full